Yanmei Xu
- Cancer Research top 5%
- MicroRNA in disease regulation 5
- Molecular Biology top 10%
- Extracellular vesicles in disease 8
- RNA Interference and Gene Delivery 3
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments 5
- Platelet Disorders and Treatments 3
-
- Inflammatory Biomarkers in Disease Prognosis 5
- Nephrology top 10%
-
- Ferroptosis and cancer prognosis 3
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
- Co-authors
- Xiaozhong WangLin JinBo HuangJing LiuXin ChenXimin ChenLinfeng HuangJing Li
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (2 papers)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Yanmei Xu
28 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Cancer Research 534
- Molecular Biology 815
- Hematology 81
- Oncology 188
- Nephrology 45
Countries citing papers authored by Yanmei Xu
This map shows the geographic impact of Yanmei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanmei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanmei Xu more than expected).
Fields of papers citing papers by Yanmei Xu
This network shows the impact of papers produced by Yanmei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanmei Xu. The network helps show where Yanmei Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yanmei Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 18 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 38 | |
| 6 | 2021 | 3 | |
| 7 | 2020 | 3 | |
| 8 | 2020 | 16 | |
| 9 | 2020 | 26 | |
| 10 | 2019 | 36 | |
| 11 | 2018 | 31 | |
| 12 | 2018 | 72 | |
| 13 | 2018 | 51 | |
| 14 | 2017 | 60 | |
| 15 | 2017 | 68 | |
| 16 | 2017 | 72 | |
| 17 | 2016 | 6 | |
| 18 | 2016 | 53 | |
| 19 | Exosomes: Novel Biomarkers for Clinical Diagnosisbreakdown → | 2015 | 463 |
| 20 | 2015 | 3 |
About Yanmei Xu
Yanmei Xu is a scholar working on Hematology, Cancer Research and Genetics, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (8 papers), MicroRNA in disease regulation (5 papers), Chronic Myeloid Leukemia Treatments (5 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers), RNA Interference and Gene Delivery (3 papers), Ferroptosis and cancer prognosis (3 papers), Platelet Disorders and Treatments (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). The work is most often cited by research in Cancer Research (534 citations), Molecular Biology (815 citations) and Hematology (81 citations). Yanmei Xu has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Xiaozhong Wang, Lin Jin, Bo Huang, Jing Liu, Xin Chen, Ximin Chen, Linfeng Huang, Jing Li, Qinghua Min and Weiming Yang. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.